Sudesh Kamath

Sudesh Kamath, PhD, is an experienced regulatory affairs leader with a strong background in Chemistry and Materials Science. Currently serving as the Head of Regulatory Affairs CMC at Corcept Therapeutics since January 2024, Sudesh has previously held senior positions at Eiger BioPharmaceuticals, QED Therapeutics, Menlo Therapeutics, and Intarcia Therapeutics, focusing on CMC regulatory strategy and oversight for various drug development programs. Sudesh's extensive experience includes leading CMC regulatory activities for complex drug-device combination products and key pharmaceutical submissions, as well as regulatory roles within the FDA. Academic credentials include a PhD in Materials Science and Engineering from Penn State University, alongside a Master's from New Mexico Institute of Mining and Technology and a Bachelor's from the Indian Institute of Technology, Bombay.